ONL Therapeutics, Inc. of Ann Arbor, MI, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-10. The offering totals $1.2M, of which $916K was reported sold. Industry: Biotechnology.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| William K Brinkerhoff | Director | Ann Arbor, MI |
| Loic K Couraud | Director | Ann Arbor, MI |
| John K Freshley | Director | Ann Arbor, MI |
| Mark K Hooper | Director | Ann Arbor, MI |
| David N Zacks | Director | Ann Arbor, MI |
| John K Freshley | Executive Officer | Ann Arbor, MI |
| David N Zacks | Executive Officer | Ann Arbor, MI |
| Felicia David-Visser | Director | Ann Arbor, MI |
| Stella Robertson | Director | El Cajon, CA |
| Rafael Castilla | Director | Stamford, CT |
| David Esposito | Director | Ann Arbor, MI |
| David Esposito | Executive Officer | Ann Arbor, MI |
| Constance Chang | Executive Officer | Ann Arbor, MI |
| Aaron Fletcher | Director | Ann Arbor, MI |
| Michal Silverberg | Director | Watertown, MA |
| Bill Burns | Director | Ann Arbor, MI |
| David Zacks | Director | Ann Arbor, MI |
| David Zacks | Executive Officer | Ann Arbor, MI |
| Marian Nakada | Director | Ann Arbor, MI |
| Mark Hooper | Director | Ann Arbor, MI |
| Christine Gibbons | Director | ANN ARBOR, MI |
| John Freshley | Director | Ann Arbor, MI |
| John Freshley | Executive Officer | Ann Arbor, MI |
| Mark A Hooper | Director | Ann Arbor, MI |
| Jeffrey A Jamison | Executive Officer | Ann Arbor, MI |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-09-16 | D | $65.0M | $60.0M |
| 2024-03-12 | D | $10.0M | $10.0M |
| 2023-03-15 | D | $15.0M | $5.0M |
| 2020-12-30 | D | $47.4M | $26.8M |
| 2020-10-30 | D | $2.0M | $2.0M |
| 2019-08-22 | D | $3.0M | $3.0M |
| 2018-09-21 | D | $1.0M | $639K |
| 2017-05-19 | D | $4.3M | $2.6M |
| 2014-06-30 | D | $1.0M | $502K |